Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that the Company expects to receive final approval from Japanese authorities to distribute CBD formulated capsules in Japan in short order.
Naturally Splendid CEO Mr. Dave Eto comments, “NSE has contributed significant work towards the application process to launch our first CBD infused products into the Japanese market through an e-commerce campaign being managed by First Step Japan (FSJ). FSJ is a marketing and distribution company located in Tokyo with extensive expertise in the Japanese consumer market. An initial order for the Japanese market has been placed in anticipation of final approval from the Japanese authorities. NSE’s Japanese specific website for this market will be activated immediately upon final approval”.
Furthermore, Naturally Splendid has received an update from Ambarri Corp regarding the sale and distribution of Ambarii’s proprietary mouth-melt full spectrum hemp CBD tablets (“Ambarii CBD Tablets”) to be marketed in Japan and South Korea under the NATERA(R) CBD brand. Initial samples incorporating Naturally Splendid’s HempOmega(TM) technology and Ambarii’s proprietary fast-acting and highly absorbantdelivery mechanism are being provided for evaluation and testing.
Ambarii CBD Tablets are quick dissolving and offer a metered dose of full spectrum hemp oil, combined with the powerful antioxidant properties of pterostilbene. The tablets will be flavor variant with zero-sugar. Ambarii CBD Tablets represent a market first and the only commercially ready tablet of its kind. The incorporation of HempOmega(TM) into this already unique offering, and is differentiator when compared to products in the same category.
Ambarii, a joint venture between NeutriSci and Lexaria Bioscience Corp, was founded to develop and utilize the proprietary and patented technology of both Neutrisci and Lexaria. Lexaria, a drug delivery platform innovator, recently announced it has received a new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for the use of its technology as a delivery platform for all cannabinoids including THC; fat soluble vitamins; non-steroidal anti-inflammatory pain medications (“NSAIDs”); and nicotine. The technology that Lexaria has recently received the Notice for Allowance from the USPTO, provides superior fast acting absorption which will be a significant differentiator for Japanese consumers looking for high quality products.
Naturally Splendid President Mr. Craig Goodwin states, “We remain confident that the products we have developed will have broad commercial appeal in Japan. We have gone through an extensive exercise to have our first CBD capsules approved for the Japanese market. And now we look forward to adding the Ambarri CBD Tablets to our on-line offerings. Naturally Splendid will continue to focus on hemp-derived Cannabidiol (CBD), the non-psychoactive cannabinoid as well as pursue additional opportunities to incorporate our HempOmega(TM) ingredient into the Ambarri formulations”.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products. Naturally Splendid is building an expanding portfolio of patents (issued and pending) and proprietary intellectual property focused on the commercial uses of industrial hemp and non-psychoactive cannabinoid compounds in a broad spectrum of applications.
Naturally Splendid currently has four innovative divisions:

  1. (1)BIOTECHNOLOGY – Focused on three major platforms:
  1. (1)Proprietary HempOmega(TM) encapsulation
  1. (2)Extraction and formulation with Cannabidiol (CBD)
  1. (3)Hemp and plant-based proteins.
  • – POS-BPC Facility – a 12,000-square-foot facility jointly operated by NSE 51% / 49% POS Holdings, offers commercial-scale custom processing solutions for functional foods and natural health.

(2) CONSUMER PRODUCTS –


  • – NATERA(R) – brand of retail hemp and superfood products distributed throughout North America, Asia and Europe.
  • – Prosnack Natural Foods Inc. (Elevate Me(TM)) – lifestyle brand of heathy meal replacement products distributed throughout North America.
  • – Chi Hemp Industries Incorporated (CHII) – e-commerce platform for natural and organic hemp products.
  • – PawsitiveFX(R) – topical pet care products.
  • – NATERA(R)CBD – retail hemp-based cannabinoid nutraceutical and cosmeceutical products distributed in Asia.
  • – NATERA(R)Skincare – brand of retail hemp based cosmeceutical products.

(3) NATERA(R) Ingredients – bulk ingredients including HempOmega(TM).
(4) Co-Packaging/Toll-Processing – packaging for house-brands (NATERA(R) and CHII) and third-party partners.
For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Dave Eto
CEO, Director
Contact Information
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail: info@naturallysplendid.com
Website: www.naturallysplendid.com
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to complete the acquisition of Prosnack, complete all or any of the proposed private placement financing, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Click here to connect with Naturally Splendid Enterprises Ltd. (TSXV:NSP) (OTCQB:NSPDF) for an Investor Presentation

Source: app.quotemedia.com

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less